DTX-P7

DTX-P7 is a peptide-drug conjugate. DTX-P7, composed of Docetaxel (DTX, HY-B0011) and a heptapeptide (P7), induces unfolded protein response and subsequent apoptosis by degrading Hsp90[1].

Product Specifications

UNSPSC

12352209

Target

Apoptosis; Eukaryotic Initiation Factor (eIF) ; HSP; Peptide-Drug Conjugates (PDCs) ; PERK

Type

Peptides

Related Pathways

Antibody-drug Conjugate/ADC Related; Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/dtx-p7.html

Smiles

O=C(OC(C)(C)C)N[C@H]([C@@H](OC(CCC(N[C@@H](CC(C)C)C(N1[C@H](C(N[C@H](C(N[C@@H]([C@H](O)C)C(N2CCC[C@H]2C(N[C@@H](CC(C)C)C(N3CCC[C@H]3C(O)=O)=O)=O)=O)=O)CC(C)C)=O)CCC1)=O)=O)=O)C(O[C@@H]4C(C)=C([C@@H](O)C([C@@]5(C)[C@]([C@@](CO6)(OC(C)=O)[C@@]6([H])C[C@@H]5O)([H])[C@@H]7OC(C8=CC=CC=C8)=O)=O)C(C)(C)[C@@]7(O)C4)=O)C9=CC=CC=C9